Detection of prostate cancer by an electronic nose: a proof of principle study.

PURPOSE We evaluate the ability of an electronic nose to discriminate prostate cancer from benign prostatic hyperplasia using urine headspace, potentially offering a clinically applicable noninvasive and rapid diagnostic method. MATERIALS AND METHODS The ChemPro® 100-eNose was used to discriminate prostate cancer from benign prostatic hyperplasia using urine sample headspace. Its performance was tested with 50 patients with confirmed prostate cancer and 24 samples from 15 patients with benign prostatic hyperplasia (15 patients provided urine preoperatively and 9 patients provided samples 3 months postoperatively) scheduled to undergo robotic assisted laparoscopic radical prostatectomy or transurethral resection of prostate, respectively. The patients provided urine sample preoperatively and those with benign prostatic hyperplasia also provided samples 3 months postoperatively to be used as a pooled control sample population. A discrimination classifier was identified for eNose and subsequently, sensitivity and specificity values were determined. Leave-one-out cross-validation was performed. RESULTS Using leave-one-out cross-validation the eNose reached a sensitivity of 78%, a specificity of 67% and AUC 0.77. CONCLUSIONS The electronic nose is capable of rapidly and noninvasively discriminating prostate cancer and benign prostatic hyperplasia using urine headspace in patients undergoing surgery.

[1]  Alphus D. Wilson,et al.  Advances in Electronic-Nose Technologies Developed for Biomedical Applications , 2011, Sensors.

[2]  A. Bjartell,et al.  Dogs sniffing urine: a future diagnostic tool or a way to identify new prostate cancer markers? , 2011, European urology.

[3]  B. Efron,et al.  Bootstrap confidence intervals , 1996 .

[4]  M. Kattan.  Factors affecting the accuracy of prediction models limit the comparison of rival prediction models when applied to separate data sets. , 2011, European urology.

[5]  M. Roobol,et al.  Risk stratification in prostate cancer screening , 2013, Nature Reviews Urology.

[6]  Giorgio Pennazza,et al.  An investigation on electronic nose diagnosis of lung cancer. , 2010, Lung cancer.

[7]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[8]  Giorgio Pennazza,et al.  A preliminary study on the possibility to diagnose urinary tract cancers by an electronic nose , 2008 .

[9]  Pär Stattin,et al.  Prostate specific antigen for early detection of prostate cancer: longitudinal study , 2009, BMJ : British Medical Journal.

[10]  Giuseppe Lippi,et al.  Article in press-uncorrected proof Mini Review Canine olfactory detection of cancer versus laboratory testing : myth or opportunity ? , 2012 .

[11]  Thomas Wiegel,et al.  EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. , 2011, European urology.

[12]  M Bolla,et al.  EAU guidelines on prostate cancer. , 2001, European urology.

[13]  Bruce J Trock,et al.  Application of metabolomics to prostate cancer. , 2011, Urologic oncology.

[14]  M. Kumar,et al.  Olfactory detection of prostate cancer by dogs sniffing urine: A step forward in early diagnosis , 2011 .

[15]  H. Haick,et al.  Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors , 2010, British Journal of Cancer.

[16]  Ian M Thompson,et al.  Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower. , 2005, JAMA.

[17]  M. Mcculloch,et al.  Diagnostic Accuracy of Canine Scent Detection in Early- and Late-Stage Lung and Breast Cancers , 2006, Integrative cancer therapies.

[18]  Yoshihiro Kakeji,et al.  Colorectal cancer screening with odour material by canine scent detection , 2011, Gut.

[19]  Alphus D. Wilson,et al.  Applications and Advances in Electronic-Nose Technologies , 2009, Sensors.

[20]  D. Johnston,et al.  Detailed mapping of prostate carcinoma foci , 2000, Cancer.

[21]  Michael N. Ferrandino,et al.  The incidence of fluoroquinolone resistant infections after prostate biopsy--are fluoroquinolones still effective prophylaxis? , 2008, The Journal of urology.

[22]  I. Ahmad,et al.  Application of Holistic Liquid Chromatography-High Resolution Mass Spectrometry Based Urinary Metabolomics for Prostate Cancer Detection and Biomarker Discovery , 2013, PloS one.

[23]  T. Lehtimäki,et al.  Detection of smell print differences between nonmalignant and malignant prostate cells with an electronic nose. , 2012, Future oncology.

[24]  Radford M. Neal.  Pattern Recognition and Machine Learning , 2007, Technometrics.

[25]  C. Willis,et al.  Olfactory detection of human bladder cancer by dogs: proof of principle study , 2004, BMJ : British Medical Journal.

[26]  G. Lippi.  Re: Jean-Nicolas Cornu,Géraldine Cancel-Tassin, Valérie Ondet, et Al. Olfactory detection of prostate cancer by dogs sniffing urine: a step forward in early diagnosis. Eur urol 2011; 59: 197-201. , 2011, European urology.

[27]  N. Draper,et al.  Applied Regression Analysis , 1967 .

[28]  William J Catalona,et al.  Serial biopsy results in prostate cancer screening study. , 2002, The Journal of urology.

[29]  HywelC. Williams,et al.  SNIFFER DOGS IN THE MELANOMA CLINIC? , 1989, The Lancet.

[30]  Gerald J. Hahn,et al.  Applied Regression Analysis (2nd Ed.) , 2012 .

[31]  Mikko Utriainen,et al.  Combining miniaturized ion mobility spectrometer and metal oxide gas sensor for the fast detection of toxic chemical vapors , 2003 .

[32]  L. J. Myers,et al.  The use of canines in the detection of human cancers. , 2008, Journal of alternative and complementary medicine.

[33]  C G Chute,et al.  Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. , 1993, JAMA.